Crossmark

Natural killer cell-based adoptive immunotherapy eradicates and drives differentiation of chemoresistant bladder cancer stem-like cells

Crossref DOI link: https://doi.org/10.1186/s12916-016-0715-2

Published Online: 2016-10-21

Published Print: 2016-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Ferreira-Teixeira, Margarida

Paiva-Oliveira, Daniela

Parada, Belmiro

Alves, Vera

Sousa, Vitor

Chijioke, Obinna

Münz, Christian

Reis, Flávio

Rodrigues-Santos, Paulo

Gomes, Célia
Funding

Funding for this research was provided by:

Astellas European Foundation Uro-Oncology Grant 2013 (II0119)

Center of Investigation in Environment, Genetics and Oncobiology (14/12)

Portuguese Foundation for Science and Technology (Pest-C/SAU/UI3282/2013; PEst-C/SAU/LA0001/2013-2014; UID/NEU/04539/2013, SFRH/BD/77314/2011)
License Information

License valid from 2016-10-21